Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Insurance coverage varies, and Medicare does not currently cover Zepbound for obesity, though the Medicare GLP-1 bridge demonstration starting July 2026 is a separate path worth knowing about if you are aging into Part D
Weight loss injections are administered under medical supervision, primarily focusing on overall body weight reduction rather than targeted fat loss
Average body weight reduction: 5 mg weekly: 16.0% reduction (approximately 35 pounds for a 220-pound person) 10 mg weekly: 21.4% reduction (approximately 47 pounds) 15 mg weekly: 22.5% reduction (approximately 50 pounds) Placebo: 2.4% reduction Percentage of participants achieving clinically significant weight loss: 5% or more weight loss: 85% at 5 mg, 89% at 10 mg, 91% at 15 mg 10% or more weight loss: 69% at 5 mg, 78% at 10 mg, 84% at 15 mg 20% or more weight loss: 32% at 5 mg, 49% at 10 mg, 57% at 15 mg Look at those numbers carefully
This step-up approach allows your body to adjust, which helps minimize uncomfortable digestive changes and improves long-term tolerance
Metabolic Effects Tirzepatides metabolic benefits extend beyond appetite control
